PATENT CLAIM ANALYSIS

Application Number: 16286955
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "211100"]

Abstract:
Compounds having the formula I wherein R 1 , X 1 , X 2 , X 3  and X 4  as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.

Claim (Index 13):
The compound of  claim 1  wherein CR 2 R 3  is in the (S) configuration.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705104', '14559786', '14568153', '13503083', '11890199']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7996039207613875
- 35 USC 102 Novelty (BERT): 0.6769241066584712
- Combined Prediction Score: 0.7873359393510959
- Mean Citation Score: 499.559878
- Max Citation Score: 726.9046599999997
- Similarity Product: 633.435854765247

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test